| OMIX007002-01 |
105 clinical cohort samples positive part7 |
15 |
Lipidome Data by Mass Spectrometry (MS) |
10.71 GB |
rar |
Controlled
|
| OMIX007002-02 |
105 clinical cohort samples positive part8 |
15 |
Lipidome Data by Mass Spectrometry (MS) |
10.52 GB |
rar |
Controlled
|
| OMIX007002-03 |
105 clinical cohort samples positive part9 |
15 |
Lipidome Data by Mass Spectrometry (MS) |
11.02 GB |
rar |
Controlled
|
| OMIX007002-04 |
105 clinical cohort samples positive part5 |
15 |
Lipidome Data by Mass Spectrometry (MS) |
10.83 GB |
rar |
Controlled
|
| OMIX007002-05 |
105 clinical cohort samples positive part4 |
15 |
Lipidome Data by Mass Spectrometry (MS) |
10.63 GB |
rar |
Controlled
|
| OMIX007002-06 |
105 clinical cohort samples positive part2 |
15 |
Lipidome Data by Mass Spectrometry (MS) |
10.63 GB |
rar |
Controlled
|
| OMIX007002-07 |
105 clinical cohort samples positive part6 |
15 |
Lipidome Data by Mass Spectrometry (MS) |
11.01 GB |
rar |
Controlled
|
| OMIX007002-08 |
105 clinical cohort samples positive part1 |
15 |
Lipidome Data by Mass Spectrometry (MS) |
10.54 GB |
rar |
Controlled
|
| OMIX007002-09 |
105 clinical cohort samples positive part3 |
15 |
Lipidome Data by Mass Spectrometry (MS) |
10.59 GB |
rar |
Controlled
|